BENJAMEN M. BINGER ELECTED TO ULTIMED BOARD OF DIRECTORS

ST. PAUL, MINNESOTA – August 25, 2004 – UltiMed has announced today that it has elected Benjamen M. Binger to its Board of Directors. With his election, the UltiMed board now consists of 6 members, 4 of whom are non-management.

Mr. Binger worked for Emergent Genetics, Inc, a private-equity firm focused on agriculture-biotechnology and is a presently partner in agriculture investment in Montana.
Ben received his BA at the University of Colorado and his MBA at Columbia University. In addition to serving on the board of UltiMed, he is a member of the Board of Directors and Chair of the Finance Committee of the McKnight Foundation. The McKnight Foundation is a Minnesota foundation with assets of $1.9 billion and annual grants of $80 million.

Tom Erickson, UltiMed's CEO said, “ Ben Binger brings to us valuable business and personal experience. I look forward to working with him as we pursue our strategy to build a great company and continue helping people live healthy lives.”

UltiMed, Inc. which is headquartered in St. Paul, Minnesota markets syringes, needles, lancets and innovative dual-purpose sharps containers for both the domestic and international markets. The Company owns and operates state of the art medical device manufacturing facilities in the U.S. and abroad. UltiMed also has a wide range of global business partners to assist in bringing its broad spectrum of medical products to customers around the world.

UltiMed Inc., 287 East 6th Street, St. Paul, MN 55101 www.ulti-care.com